Recent news on Isosorbide Dinitrate

NitroMed Announces Sale of Common Stock  -  May 24, 2007
Business Wire (press release),NitroMed of Lexington, Massachusetts is an emerging pharmaceutical company and the maker of BiDil ® (isosorbide dinitrate/hydralazine hydrochloride),

NitroMed To Report Financial Results for First Fiscal Quarter 2007  -  Apr 25, 2007
PharmaLive.com (press release),NitroMed of Lexington, Massachusetts is an emerging pharmaceutical company and the maker of BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride),

Zacks.com Announces That Dr. Scott W. & Nadine Wong Highlight the ...  -  Apr 4, 2007
Business Wire (press release),BiDil is a combination of two drugs, isosorbide dinitrate and hydralazine. BiDil was approved on the basis that it could effectively reduce mortality and

Awareness is the first step to better heart health in women  -  Feb 21, 2007
Walker Pilot Independent,...heart pumps ineffectively), the University of Minnesota conducted a study on the use of the drug combination of isosorbide dinitrate and hydralazine.

NitroMed (NTMD) Announces License Agreement with Elan Pharma (ELN)  -  Feb 12, 2007
StreetInsider.com (subscription),...as its sole active combination of ingredients, the combination of the active drug substances isosorbide dinitrate and hydralazine hydrochloride.

BiDil for Heart Failure in Black Patients: The US Food and Drug ...  -  Jan 2, 2007
Annals of Internal MedicineCritics of the US Food and Drug Administration (FDA) approval of the fixed combination of hydralazine hydrochloride, 37.5 mg, and isosorbide dinitrate,

CORRECTING and REPLACING NitroMed to Present at JPMorgan ...  -  Jan 4, 2007
Genetic Engineering News (press release),NitroMed of Lexington, Massachusetts is an emerging pharmaceutical company and the maker of BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride),

Vasodilators for chronic HF and low BP? A-HeFT analysis supports ...  -  Jan 12, 2007
TheHeart.Org,...of the fixed-dose vasodilator combination of isosorbide dinitrate and hydralazine (ISDN-H) (BiDil, NitroMed) weren't related to changes in BP [1].

Facts About Heart Failure Medications  -  Jan 4, 2007
Oak Park Journal,Combination Isosorbide Dinitrate and Hydralazine Pills – this combination is called a vasodilator because it relaxes blood vessels and eases the work of the

BiDil for Heart Failure in Black Patients: Implications of the US ...  -  Jan 2, 2007
Annals of Internal MedicineIn 2005, the combination of hydralazine hydrochloride and isosorbide dinitrate was approved by the US Food and Drug Administration (FDA) for treating heart

Comparison of the prognostic value of SPECT after nitrate ...  -  Dec 21, 2006
HeartZine,...underwent (99m)Tc-tetrofosmin SPECT under control conditions (baseline) and after sublingual administration of 10 mg of isosorbide dinitrate (nitrate).

Comparison of the prognostic value of SPECT after nitrate ...  -  Dec 21, 2006
HeartZine,...underwent (99m)Tc-tetrofosmin SPECT under control conditions (baseline) and after sublingual administration of 10 mg of isosorbide dinitrate (nitrate).

Medicare should cover drug that helps blacks Very few can now ...  -  Dec 15, 2006
Ann Arbor News,BiDil is made up of two generic chemicals, isosorbide dinitrate and hydralazine which some companies cover. However, the two drugs haven't been approved

NitroMed (NTMD) Reports a Q3 Loss of $0.45  Nov 2, 2006
NitroMed of Lexington, Massachusetts is an emerging pharmaceutical company and the maker of BiDil® (isosorbide dinitrate/hydralazine hydrochloride), an orally ... -StreetInsider.com (subscription), NitroMed Reports Financial Results for Third Quarter 2006  Nov 2, 2006
Net sales of BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride) accounted for all of the Company's revenue during the first nine months of 2006, and ... -Genetic Engineering News (press release), NitroMed Third Quarter 2006 Earnings Call and Webcast To Be Held ...  Oct 26, 2006
NitroMed of Lexington, Massachusetts is an emerging pharmaceutical company and the maker of BiDil ® (isosorbide dinitrate/hydralazine hydrochloride), an ... -Business Wire (press release), NitroMed Revises Sales and Marketing Strategy - Accelerates ...  Oct 11, 2006
...intended to focus its resources on the accelerated development of an extended release formulation of BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride ... -Genetic Engineering News (press release), Heart medication for blacks faces uphill battle  Oct 16, 2006
BiDil is a so-called combination drug made up of two chemicals, isosorbide dinitrate and hydralazine. Both are available in generic forms. ... -Pittsburgh Post Gazette, Cost, Access Issues Result in Slow Adoption of BiDil for Blacks ...  Oct 16, 2006
Additionally, many insurers maintain that BiDil is no more effective than the two generic chemicals it is made up of -- isosorbide dinitrate and hydralazine ... -Kaiser network.org, Publicado: Sab Oct 14, 2006 5:01 pm Asunto: Unless directed to do ...  Oct 14, 2006
...dont h. isordil ve enough ego to claim it was just for Jim!), and she no isosorbide dinitrate iced the difference immediately. So ... -Shell Security, New BiDil Data Highlighted at Annual Heart Failure Society of ...  Sep 11, 2006
...(NASDAQ:NTMD) announced today that five poster presentations highlighting new findings related to BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride ... -Genetic Engineering News

NitroMed to Present at UBS Global Life Sciences Conference ...  Sep 19, 2006
NitroMed of Lexington, Massachusetts is an emerging pharmaceutical company and the maker of BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride), an ... -Business Wire

Likely genetic marker for heightened response to ISDN-hydralazine ...  Sep 13, 2006
Seattle, WA - The clinical effectiveness of therapy with a fixed-dose combination of isosorbide dinitrate (ISDN) and hydralazine (BiDil, NitroMed) in blacks ... -TheHeart.Org

Improve access to heart drug  -  Dec 11, 2006
The Grand Rapids Press,BiDil is made up of two generic chemicals, isosorbide dinitrate and hydralazine which some companies cover. However, the two drugs haven't been approved

How to be PDQ on your PDA – Adaptex goes live  -  Nov 13, 2006
E-consultancy,Few doctors would look forward to typing in ‘reorder prescription for isosorbide dinitrate and Sorbitrate’ into a PDA, but with Adaptex it can be done in

NitroMed Reports Financial Results for Second Quarter 2006 ...  Aug 3, 2006
Product sales of BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride) accounted for all of the Company's revenue during the first half of 2006. ... -Business Wire

NitroMed Second Quarter 2006 Earnings Call and Webcast to Be Held ...  Jul 27, 2006
NitroMed of Lexington, Massachusetts is an emerging pharmaceutical company and the maker of BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride), an ... -PharmaLive.com

Health Leaders Urge Improved Quality of Care for Black Patients ...  Jun 22, 2006
BiDil, a patented fixed-dose combination of isosorbide dinitrate and hydralazine, was approved by the US Food and Drug Administration (FDA) as the first-ever ... -U.S. Newswire



FDA Confirms No Drugs are Therapeutically Equivalent to BiDil(R)  May 4, 2006
...not approved any drug that is therapeutically equivalent or substitutable to BiDil, the fixed-dose combination of isosorbide dinitrate/hydralazine hydrochloride ... - Genetic Engineering News

NitroMed Reports Financial Results for First Quarter 2006 ...  May 2, 2006
Product sales of BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride) accounted for all of the Company's revenue during the first quarter of 2006, and ... - Genetic Engineering News

NitroMed Says FDA Confirms No Drug Therapeutically Equivalent Or ...  May 4, 2006
Moreover, the FDA confirmed that neither approved labeling for isosorbide dinitrate nor approved labeling for hydralazine hydrochloride contains information ... - Trading Markets

Heart Drug Side Effects More Common in Minority Patients  May 5, 2006
...after a carefully controlled trial showed beneficial results for BiDil, a medication that combines two agents, hydralazine and isosorbide dinitrate, in that ... - Forbes

NitroMed to Present at Morgan Stanley's Global Healthcare ...  Apr 27, 2006
...will discuss the Company's progress and plans, particularly with respect to the commercial launch of BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride ... - Genetic Engineering News

NitroMed First Quarter 2006 Earnings Call and Webcast Scheduled ...  Apr 24, 2006
NitroMed of Lexington, Massachusetts is an emerging pharmaceutical company and the maker of BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride), an ... - PharmaLive.com



Researchers Identify Gene Variations That May Determine Which ...  Mar 13, 2006
...the African American Heart Failure Trial (A-HeFT), the clinical trial supporting effectiveness of BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride ... - International News Service

NitroMed Restructures R&D Operations; Extended Release BiDil(R) ...  Mar 30, 2006
The Company will focus on the continued development of both an extended release formulation of BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride), as ... - Genetic Engineering News

African American Heart Failure Trial Shows Women and Men Both ...  Mar 14, 2006
...gender, which demonstrated similar positive clinical outcomes for both black men and black women taking BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride ... - Genetic Engineering News

Clinical Response to BiDil(R) Evaluated by Baseline Blood Pressure ...  Mar 13, 2006
Today, NitroMed, Inc. (NASDAQ:NTMD) announced data from a continuing analysis of patients treated with BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride ... - Genetic Engineering News

Clinical Response to BiDil(R) Evaluated by Baseline Blood Pressure ...  Mar 13, 2006
...(NASDAQ:NTMD) announced data from a continuing analysis of patients treated with BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride) in the African ... - Business Wire

When Discrimination Saves Lives  Mar 29, 2006
...of Lexington, Massachusetts, combines isosorbide dinitrate and hydralazine hydrochloride, which cause arteries and veins to dilate and allow blood to flow ... - Pennsylvania Independent

NitroMed Cuts Back R&D To Ready For BiDil Sales Push  Apr 3, 2006
BiDil consists of a combination of two generic drugs, isosorbide dinitrate and hydralazine hydrochloride, taken three times per day. ... - BioWorld Online (subscription)

Heart Drug for Blacks Is a Disappointment to Its Maker  Mar 21, 2006
73 cents. BiDil is a combination of two generic drugs that were already available, isosorbide dinitrate and hydralazine. When combined ... - New York Times

NitroMed Board Appoints New Senior Management  Mar 21, 2006
...of Lexington, Massachusetts is a research-based emerging pharmaceutical company and the maker of BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride), an ... - Genetic Engineering News

BiDil Benefits All Black Heart Failure Patients: Study  Mar 14, 2006
...the African American Heart Failure Trial (A-HeFT) showed that both women (228) and men (290) treated with BiDil (isosorbide dinitrate/hydralazine hydrochloride ... - KPHO Phoenix



NitroMed Reports Financial Results for Fourth Quarter and Full ...  Mar 2, 2006
Of total revenue, BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride) product sales accounted for $3.3 million during the fourth quarter, $4.5 million ... - Genetic Engineering News,

Rotarix Approved In Europe; Avant Due $40M At Launch  Feb 27, 2006
The compound is a fixed-dose combination of the generic drugs isosorbide dinitrate and hydralazine (See BioWorld Today, June 27, 2005.). ... - BioWorld Online (subscription),

New Guidelines Released for Heart Failure Treatment  Feb 16, 2006
The HFSA guidelines also address and recommend the use of a combination of isosorbide dinitrate and hydralazine, which has been demonstrated to be highly ... - DG News

What is Viagra  Feb 13, 2006
...ointments, skin patches or pastes, and tablets that are swallowed or dissolved in the mouth ) isosorbide mononitrate and isosorbide dinitrate ( tablets that ... - I-Newswire.com

NitroMed to Present at BIO CEO & Investor Conference; February 14 ...  Feb 7, 2006
Executive Officer, will present a corporate overview and progress report on the commercial launch of BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride ... - Genetic Engineering News

Smoking Out Cliches About Race  Feb 2, 2006
...treatment of heart failure, BiDil--a combination drug containing a diuretic (hydralazine) and a nitric oxide enhancer (isosorbide dinitrate)--made headlines ... - American Enterprise Institute

NitroMed Announces Sale of Common Stock  Jan 25, 2006
...corporate purposes, including the continued commercial launch of NitroMed's first marketed product, BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride). ... - Genetic Engineering News

NitroMed Sells Stock  Jan 25, 2006
...corporate purposes, including the continued commercial launch of NitroMed's first marketed product, BiDil (isosorbide dinitrate/hydralazine hydrochloride). - TheStreet.com

Gerald W. Bruce Joins NitroMed as Vice President, Sales  Jan 17, 2006
Mr. Bruce's early focus will be on the continued field launch of BiDil(R) (isosorbide dinitrate/hydralazine), NitroMed's first marketed product, the ... - Genetic Engineering News

NitroMed $62.5M Placement Supporting Growth Of BiDil  Jan 25, 2006
Mass.-based company intends to use the proceeds for general corporate purposes, including commercializing BiDil (isosorbide dinitrate/hydralazine hydrochloride ... - BioWorld Online (subscription)

NitroMed Announces Optimization of BiDil(R) Contract Sales Force  Jan 20, 2006
...agreement with Publicis Selling Solutions has been modified to now staff 144 of the original 195 BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride ... - Genetic Engineering News

NitroMed Promotes Michael Sabolinski, MD to the Position of Chief ...  Jan 7, 2006
...efforts, and participate in certain key decision making processes relative to the development of BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride ... - New Age Media Concepts

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional